Moneycontrolresearch

The management remains optimistic about outperforming industry growth, supported by a robust pipeline of new products, stronger aftermarket business, and favourable regulatory developments

Is the fertiliser sector becoming investment worthy?

The latest GST reforms address the key issue of the inverted duty structure

Krsnaa Diagnostics: Chasing new avenues for growth

Optimistic guidance for FY26; the B2C segment should act as a key growth lever

Rainbow Children’s Medicare: A high-potential, high-execution play

The Indian healthcare market is experiencing robust growth and the hospital chain is uniquely placed in the paediatric segment

Global Health: In the pink of health, but growth will come at a price

Demand for high-end healthcare facilities remains strong; however, the company’s valuation appears demanding

Apollo Hospital: Growth momentum continues in Q1 FY26

Robust expansion plans in place, with a target of about 4,000 beds in the next 3-4 years

Bluestone Jewellery and Lifestyle IPO: Will it shine on the bourses?

The company is not profitable at the moment and may continue to make losses in the near term

Bosch Q1 FY26: Is the auto ancillary stock racing too fast?

Bosch is planning to strengthen its competitive position in the mobility sector and industrial technology. It is actively adding new components, particularly those catering to EVs and advanced electronics.

Gabriel India: Primed for growth but priced to perfection

Forays into new segments like sunroof, inorganic and organic strategies show the company’s confidence in the future.

SJS Enterprises Q1 FY26: On track to meet growth targets

SJS expects to grow at 2x the industry volume in FY26 and maintain a ~26 percent margin level.

Brigade Hotel Ventures: Does the IPO offer a good investment opportunity?

The hotelier’s return ratios are solid and the stock valuation is attractive while part of the IPO money will support growth plans

Optimism low on this healthcare stock

Medanta has strong capabilities to leverage its brand image. However, near-term growth looks limited

How is the health of this healthcare stock?

Timely execution and ramp-up of new projects are crucial for faster growth

This hospital chain is aiming for high growth, but is it already priced in?

Max is on an aggressive expansion path with healthy medium-term growth visibility

Apollo Hospitals: Annual report card ticks all the right boxes

Robust expansion plans in place with the target to add a total of about 4000 beds in the next 3-4 years

Rallis India: Stars align in Q2, what does its pitch report say?

The company is focusing on optimising portfolio and streamlining capacities

What does Advent Group’s equity infusion mean for Apollo Hospital stock?

After the integration of Keimed with AHL, Advent will hold a 12.1% stake in the combined entity.

Max Healthcare: A healthy but pricey stock

The healthcare company’s medium-term revenue growth visibility appears healthy

Medanta: Charting a growth path

Medanta has strong capabilities to leverage its brand image and win the underserved and growing markets.

KIMS: Why are we turning optimistic on this healthcare stock?

KIMS is well-positioned to seize the growing demand for healthcare facilities in the country. Timely execution and ramp-up of new projects will be crucial

NMDC Q1 FY25: Strong profit growth unlikely to stage a repeat show

The company has reduced prices for iron ore lumps and fines by 10 percent each

Hindalco: Tepid performance from Novelis in Q1 FY25

Demand environment across end-use segments remains a mixed bag

Vijaya Diagnostic Centre: Why this test result excites us

Focused on replicating its home market success in the eastern and western regions of the country.

Coal India: Decent show in Q1 FY25; levers in place for long-term gain

India’s power demand is expected to see solid growth in the coming years

Maruti’s Q1FY25: Maintains speed riding on a rich product mix

Lower raw material costs and a host of other factors helped the company beat Street expectations on its performance